Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons
Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZ...
Gespeichert in:
Veröffentlicht in: | Synapse (New York, N.Y.) N.Y.), 1997-06, Vol.26 (2), p.184-193 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 193 |
---|---|
container_issue | 2 |
container_start_page | 184 |
container_title | Synapse (New York, N.Y.) |
container_volume | 26 |
creator | Meltzer, Leonard T. Serpa, Kevin A. Christoffersen, Curt L. |
description | Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1098-2396(199706)26:2<184::AID-SYN9>3.0.CO;2-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78981800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78981800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</originalsourceid><addsrcrecordid>eNqFkV1rFDEYhYModa3-BGGupL2YNZlkMslahDradaF2xdavq5fMTGYbnS-TDLb_3kx3WS8UCoHwvpycQ86D0AnBc4Jx8vLocpWvjgmWIk6o5EdEygzz44QvkhMi2GJxunobX36_kK_pHM_z9askZg_QbP_gIZphIbKYsYw_Rk-c-4ExpgSzA3QgCSVZls3Q5oP2qui97QdTRptm9KpVXkdWl3rwvY1bXZmwqCLTXZvCeNN3keqqSN-Uxqu7sa8jNxbOq84bFXVmY1VU9YNqTaejTo-279xT9KhWjdPPdvch-nz27ip_H5-vl6v89DwuWSJlLJnGmDPOq1qVtOJcpYKR8G1cphQTxhllMpVKMqrLUme6rrWoCyoIq1hdK3qIXmx9B9v_GrXz0BpX6qZRne5HB5mQgojQw31CwiljhCRBeLUVlrZ3zuoaBmtaZW-BYJhAAUygYOodpt5hCwqScCCAAgigYAIFFDDk67Bmwfb5Ln8sQsd70x2Zv7G_TaNv_8m8J_I_iXdzsI23tsZ5fbO3VfYn8IxmKXy9WEL67Q1fnn35CJ_oH9davq4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16344112</pqid></control><display><type>article</type><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</creator><creatorcontrib>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</creatorcontrib><description>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/(SICI)1098-2396(199706)26:2<184::AID-SYN9>3.0.CO;2-4</identifier><identifier>PMID: 9131777</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>1S,3R‐ACPD ; 3R-ACPD ; Animals ; Cycloleucine - analogs & derivatives ; Cycloleucine - pharmacology ; Dopamine - metabolism ; Dose-Response Relationship, Drug ; electrophysiology ; ionotropic glutamate receptors ; Male ; Neurons - drug effects ; Neuroprotective Agents - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Metabotropic Glutamate - drug effects ; Receptors, Metabotropic Glutamate - physiology ; Substantia Nigra - drug effects</subject><ispartof>Synapse (New York, N.Y.), 1997-06, Vol.26 (2), p.184-193</ispartof><rights>Copyright © 1997 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2396%28199706%2926%3A2%3C184%3A%3AAID-SYN9%3E3.0.CO%3B2-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2396%28199706%2926%3A2%3C184%3A%3AAID-SYN9%3E3.0.CO%3B2-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9131777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meltzer, Leonard T.</creatorcontrib><creatorcontrib>Serpa, Kevin A.</creatorcontrib><creatorcontrib>Christoffersen, Curt L.</creatorcontrib><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</description><subject>1S,3R‐ACPD</subject><subject>3R-ACPD</subject><subject>Animals</subject><subject>Cycloleucine - analogs & derivatives</subject><subject>Cycloleucine - pharmacology</subject><subject>Dopamine - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>electrophysiology</subject><subject>ionotropic glutamate receptors</subject><subject>Male</subject><subject>Neurons - drug effects</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Metabotropic Glutamate - drug effects</subject><subject>Receptors, Metabotropic Glutamate - physiology</subject><subject>Substantia Nigra - drug effects</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFDEYhYModa3-BGGupL2YNZlkMslahDradaF2xdavq5fMTGYbnS-TDLb_3kx3WS8UCoHwvpycQ86D0AnBc4Jx8vLocpWvjgmWIk6o5EdEygzz44QvkhMi2GJxunobX36_kK_pHM_z9askZg_QbP_gIZphIbKYsYw_Rk-c-4ExpgSzA3QgCSVZls3Q5oP2qui97QdTRptm9KpVXkdWl3rwvY1bXZmwqCLTXZvCeNN3keqqSN-Uxqu7sa8jNxbOq84bFXVmY1VU9YNqTaejTo-279xT9KhWjdPPdvch-nz27ip_H5-vl6v89DwuWSJlLJnGmDPOq1qVtOJcpYKR8G1cphQTxhllMpVKMqrLUme6rrWoCyoIq1hdK3qIXmx9B9v_GrXz0BpX6qZRne5HB5mQgojQw31CwiljhCRBeLUVlrZ3zuoaBmtaZW-BYJhAAUygYOodpt5hCwqScCCAAgigYAIFFDDk67Bmwfb5Ln8sQsd70x2Zv7G_TaNv_8m8J_I_iXdzsI23tsZ5fbO3VfYn8IxmKXy9WEL67Q1fnn35CJ_oH9davq4</recordid><startdate>199706</startdate><enddate>199706</enddate><creator>Meltzer, Leonard T.</creator><creator>Serpa, Kevin A.</creator><creator>Christoffersen, Curt L.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199706</creationdate><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><author>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>1S,3R‐ACPD</topic><topic>3R-ACPD</topic><topic>Animals</topic><topic>Cycloleucine - analogs & derivatives</topic><topic>Cycloleucine - pharmacology</topic><topic>Dopamine - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>electrophysiology</topic><topic>ionotropic glutamate receptors</topic><topic>Male</topic><topic>Neurons - drug effects</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Metabotropic Glutamate - drug effects</topic><topic>Receptors, Metabotropic Glutamate - physiology</topic><topic>Substantia Nigra - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meltzer, Leonard T.</creatorcontrib><creatorcontrib>Serpa, Kevin A.</creatorcontrib><creatorcontrib>Christoffersen, Curt L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meltzer, Leonard T.</au><au>Serpa, Kevin A.</au><au>Christoffersen, Curt L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>1997-06</date><risdate>1997</risdate><volume>26</volume><issue>2</issue><spage>184</spage><epage>193</epage><pages>184-193</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>9131777</pmid><doi>10.1002/(SICI)1098-2396(199706)26:2<184::AID-SYN9>3.0.CO;2-4</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0887-4476 |
ispartof | Synapse (New York, N.Y.), 1997-06, Vol.26 (2), p.184-193 |
issn | 0887-4476 1098-2396 |
language | eng |
recordid | cdi_proquest_miscellaneous_78981800 |
source | MEDLINE; Wiley Journals |
subjects | 1S,3R‐ACPD 3R-ACPD Animals Cycloleucine - analogs & derivatives Cycloleucine - pharmacology Dopamine - metabolism Dose-Response Relationship, Drug electrophysiology ionotropic glutamate receptors Male Neurons - drug effects Neuroprotective Agents - pharmacology Rats Rats, Sprague-Dawley Receptors, Metabotropic Glutamate - drug effects Receptors, Metabotropic Glutamate - physiology Substantia Nigra - drug effects |
title | Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A03%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabotropic%20glutamate%20receptor-mediated%20inhibition%20and%20excitation%20of%20substantia%20nigra%20dopamine%20neurons&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Meltzer,%20Leonard%20T.&rft.date=1997-06&rft.volume=26&rft.issue=2&rft.spage=184&rft.epage=193&rft.pages=184-193&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/(SICI)1098-2396(199706)26:2%3C184::AID-SYN9%3E3.0.CO;2-4&rft_dat=%3Cproquest_cross%3E78981800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16344112&rft_id=info:pmid/9131777&rfr_iscdi=true |